Multi-age cohort campaigns had a marked effect on vaccine-type carriage and fractional-dose campaigns met non-inferiority criteria. Such campaigns should be considered in low-coverage settings, including humanitarian emergencies, to accelerate populati...
Pneumococcal conjugate vaccines (PCVs) are highly effective but have a very low coverage (
Dondorp AM. MMV533, a promising new antimalarial on the horizon. Lancet Infect Dis 2024; published online Dec 18. https://doi.org/10.1016/S1473-3099(24)00730-8—In this Comment, the fourth sentence of the second paragraph should read “…at 20 mg, which i...
Hamtandi M Natama and colleagues conducted a clinical trial on the efficacy and safety of the RH5.1/Matrix-M vaccine, a candidate malaria vaccine, in children aged 5–17 months in Burkina Faso and published its interim results in The Lancet Infectious D...
Hamtandi M Natama and colleagues conducted a clinical trial on the efficacy and safety of the RH5.1/Matrix-M vaccine, a candidate malaria vaccine, in children aged 5–17 months in Burkina Faso and published its interim results in The Lancet Infectious D...
Garcia Quesada M, Peterson ME, Bennett JC, et al. Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis. ...
Garcia Quesada M, Peterson ME, Bennett JC, et al. Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis. ...
Borna disease, which is a severe encephalitis that primarily affects horses and sheep, has been recognised for over two centuries. Borna disease virus 1 (BoDV-1) has been identified as a cause of a predominantly fatal encephalitis in humans. Little sci...
Borna disease, which is a severe encephalitis that primarily affects horses and sheep, has been recognised for over two centuries. Borna disease virus 1 (BoDV-1) has been identified as a cause of a predominantly fatal encephalitis in humans. Little sci...
We appreciate the interest and thoughtful analysis by Silvano Wendel and colleagues of our Correspondence regarding the risk of transfusion-transmitted dengue virus (TT-DENV) during Brazil's largest recorded dengue outbreak.1 We value the opportunity t...
We appreciate the interest and thoughtful analysis by Silvano Wendel and colleagues of our Correspondence regarding the risk of transfusion-transmitted dengue virus (TT-DENV) during Brazil's largest recorded dengue outbreak.1 We value the opportunity t...
We read the Correspondence by Flávia Jacqueline Almeida and colleagues1 with interest. Dengue has affected millions of people annually, with many asymptomatic cases, where the likelihood of viraemic (RNAaemic) blood donors cannot be disregarded.
We read the Correspondence by Flávia Jacqueline Almeida and colleagues1 with interest. Dengue has affected millions of people annually, with many asymptomatic cases, where the likelihood of viraemic (RNAaemic) blood donors cannot be disregarded.
Historically, sickle cell anaemia has been widely neglected within its global epicentre of sub-Saharan Africa. More than 300 000 children are born with sickle cell anaemia within the region every year.1 Until recently, most of these children would not ...
Malaria chemoprophylaxis with weekly dihydroartemisinin–piperaquine in children with sickle cell anaemia is safe and considerably more efficacious than monthly sulfadoxine–pyrimethamine. However, monthly sulfadoxine–pyrimethamine was associated with fe...
Since late 2023, more than 10 000 locally acquired cases of Oropouche virus have been reported in the Americas.1 Here, we describe the first cluster of Oropouche virus imported into France from Cuba, where transmission has been ongoing since at least M...